Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) › Capital ExpendituresCordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2021: $100.0K2022: $4752023: $319.5K2024: $349.2K$349.2K2021Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$349.2K+9.3%2023$319.5K+67160.4%2022$475-99.5%2021$100.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share